Which are the causes of Legg-Calvé-Perthes disease?

TL;DR: Legg-Calvé-Perthes disease is characterized by the temporary loss of blood supply to the head of the femur (thigh bone), leading to bone death and eventual remodeling. While the exact cause remains idiopathic—meaning it is not fully understood—research suggests it is likely triggered by a combination of localized clotting abnormalities, developmental delays, and subtle genetic predispositions.

What causes the blood supply to fail in Legg-Calvé-Perthes disease?

The core mechanism of Legg-Calvé-Perthes disease is avascular necrosis, which essentially means "bone death due to lack of blood." Think of the hip joint like a garden: the head of the femur is the plant, and the blood vessels are the irrigation system. In children with Legg-Calvé-Perthes disease, the "irrigation" is interrupted for reasons we are still investigating. This causes the bone tissue to weaken and collapse. Over time, the body attempts to revascularize the area, leading to a phase of bone resorption and eventual healing, though the shape of the hip may be permanently altered.

Is Legg-Calvé-Perthes disease genetic or hereditary?

While Legg-Calvé-Perthes disease is not considered a strictly inherited "Mendelian" disorder (like cystic fibrosis), clinical geneticists have observed familial clustering. In a small percentage of cases, researchers have identified mutations in the COL2A1 gene, which is responsible for type II collagen production, essential for healthy bone and cartilage development. However, for the vast majority of families, there is no single "Legg-Calvé-Perthes disease gene." Instead, we believe there may be a polygenic predisposition, where a child inherits a combination of minor genetic variations that make their hip blood supply more susceptible to disruption.

What are the known risk factors and environmental triggers?

Distinguishing between a "cause" and a "risk factor" is vital; a cause is the direct agent of disease, while a risk factor increases the likelihood of occurrence. Current research points to several factors that correlate with the onset of Legg-Calvé-Perthes disease:

• Age and Gender: The condition most frequently affects children between the ages of 4 and 10 and is approximately 4 to 5 times more common in boys than in girls.


• Hypercoagulability: Some children with Legg-Calvé-Perthes disease exhibit blood-clotting disorders (thrombophilia), which may lead to micro-clots that block the small vessels supplying the hip.


• Low Birth Weight: Epidemiological studies have noted a higher incidence in children who were small for their gestational age.


• Passive Smoke Exposure: Several studies have suggested a statistical association between exposure to secondhand smoke and the development of the condition.


• Skeletal Maturity: Children with this diagnosis often show a "bone age" that is delayed compared to their chronological age.

What is the current state of medical research?

Medical researchers are actively moving beyond the "idiopathic" label to understand the etiology of Legg-Calvé-Perthes disease. Current studies are focusing on the role of the coagulation system and inflammatory markers. By analyzing data from communities like the 227 members on DiseaseMaps.org, clinicians are gaining better insights into the natural history of the disease. Ongoing research into advanced imaging and metabolic profiling aims to identify children at risk before the femoral head begins to collapse, which would be a major breakthrough in managing Legg-Calvé-Perthes disease.

Next steps

• Consult a Pediatric Orthopedist: If you suspect your child has symptoms, seek an evaluation from a specialist who has experience with hip-preserving treatments.


• Join the Community: Connect with the 227 other families on DiseaseMaps.org to share experiences and coping strategies for managing Legg-Calvé-Perthes disease.


• Monitor Growth: Keep detailed records of your child’s physical development, as growth patterns are often discussed during clinical consultations.


• Participate in Research: Ask your physician about local or national registries for Legg-Calvé-Perthes disease that may be recruiting for longitudinal studies.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Legg-Calvé-Perthes disease overview.


• Orphanet: Portal for rare diseases and orphan drugs (ORPHA:3198).


• OMIM (Online Mendelian Inheritance in Man): Entry #150600 regarding Legg-Calvé-Perthes disease.


• International Perthes Study Group: Clinical research and consensus on treatment protocols.